Clinical islet transplantation is viewed as a viable treatment that has the potential to eliminate a life-long dependence on insulin in individuals with type 1 diabetes (T1D). Dr. Shapiro breaks down the three areas his research study will focus on.
Dr. Anne Maria Pesenacker, a JDRF-funded investigator at the University of British Columbia and now at UCL’s Institute of Immunity and Transplantation, is examining how regulatory T cells (Tregs) function in health and how best to monitor their fitness.
The development of encapsulation technologies to treat insulin-dependent diabetes has been at the forefront of type 1 diabetes (T1D) research in North America for many years. This is because new methods of cell delivery may offer a functional cure for people with T1D at high risk for life-threating complications.
It goes without saying that social media has become the way we share snippets of our lives. Not only has it revolutionized how we get a glimpse into those of our friends and family, but it has radically changed how we learn about the world around us, how we engage with government and how we unite to make our planet a better place to live.
Guest blog post by Nguyet (Na) Nguyen and Sarah Strong
The Provincial Day of Action is a yearly event where medical students identify a gap in the healthcare system and approach our provincial government with an “ask” to help fix that gap. This year, as students in the Faculty of Medicine at Memorial University of Newfoundland, we asked the provincial government to remove the age restrictions in place for financial coverage of insulin pumps for people living with type 1 diabetes (T1D) in Newfoundland and Labrador.
While the 2019 Canadian budget was eagerly anticipated by all Canadians, there were items that directly impacted members of the type 1 diabetes (T1D) community. So what does the 2019 federal budget mean for you?
Ashlynn O’Hara is 10 years old, lives with type 1 diabetes (T1D), and is taking her fight for affordable continuous glucose monitors (CGM) to the big leagues.
The results of the Ontario budget mean that your voice is now more important than ever. You can immediately support this initiative by writing, calling or meeting with your provincial or territorial representative by simply clicking here.
Having someone with the lived experience of diabetes relate their struggles with maintaining good blood glucose to political representatives and get across just how life-changing, in some cases life-saving, CGM and FGM devices can be, changes the whole conversation.
This month, twenty years ago, a pioneering clinical trial in Alberta marked a major advancement in islet transplantation for the treatment of type 1 diabetes (T1D).
We are pleased to announce Dr. Sarah Linklater has been appointed as Chief Scientific Officer (CSO).
Recently, a team of researchers in the United States developed a test to identify individuals of African descent who are more likely to get the disease.
